Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients

NCT02062983 · clinicaltrials.gov ↗

SUSPENDED

Status

50

Enrollment

OTHER_GOV

Sponsor class

Stopped Difficulty in enrolling patients

Conditions

Breast Cancer

Interventions

DRUG: Herceptin

Sponsor

National Guard Health Affairs